PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+9.92%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.61B
AUM Growth
+$2.61B
(+2.1%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
32.6%
Holding
88
New
10
Increased
24
Reduced
13
Closed
7
Top Buys
| 1 |
Biogen
BIIB
|
$37.2M |
| 2 |
PNT
POINT Biopharma Global Inc. Common Stock
PNT
|
$34.9M |
| 3 |
Penumbra
PEN
|
$33.6M |
| 4 |
HCA Healthcare
HCA
|
$32.2M |
| 5 |
Prothena Corp
PRTA
|
$30M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$78M |
| 2 |
Pfizer
PFE
|
$70.4M |
| 3 |
Merck
MRK
|
$52.7M |
| 4 |
Becton Dickinson
BDX
|
$32.2M |
| 5 |
Universal Health Services
UHS
|
$32M |
Sector Composition
| 1 | Healthcare | 93.65% |
| 2 | Financials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$4.23B
| $119M | 4.32% | 2,465,016 | – | – |
|
2
Eli Lilly
LLY
$657B
| $96.6M | 3.49% | 298,643 | – | – |
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $94.6M | 3.42% | 1,115,949 +276,578 | +33% | +$23.4M |
|
4
Arcus Biosciences
RCUS
$1.13B
| $88.5M | 3.2% | 3,383,233 +36,775 | +1% | +$962K |
|
5
Centene
CNC
$14.3B
| $86.6M | 3.13% | 1,112,480 | – | – |
|
6
Humana
HUM
$36.5B
| $80.6M | 2.92% | 166,066 | – | – |
|
7
Jazz Pharmaceuticals
JAZZ
$7.75B
| $76.2M | 2.76% | 571,936 | – | – |
|
8
Axsome Therapeutics
AXSM
$6.05B
| $74.1M | 2.68% | 1,659,733 +299,137 | +22% | +$13.3M |
|
|
9
Penumbra
PEN
$10.6B
| $68.3M | 2.47% | 360,030 +177,244 | +97% | +$33.6M |
|
|
HZNP
10
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $67.6M | 2.44% | 1,091,840 | – | – |
|
11
Caribou Biosciences
CRBU
$174M
| $63.3M | 2.29% | 6,000,000 | – | – |
|
12
iRhythm Technologies
IRTC
$5.46B
| $61.9M | 2.24% | 493,721 | – | – |
|
13
Erasca
ERAS
$445M
| $56.7M | 2.05% | 7,264,981 +1,383,599 | +24% | +$10.8M |
|
14
UnitedHealth
UNH
$281B
| $56.3M | 2.04% | 111,554 | – | – |
|
|
15
Prothena Corp
PRTA
$441M
| $50.9M | 1.84% | 840,238 +495,124 | +143% | +$30M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $50M | 1.81% | 365,215 +82,820 | +29% | +$11.3M |
|
17
Molina Healthcare
MOH
$9.8B
| $47.4M | 1.72% | 143,779 | – | – |
|
18
Danaher
DHR
$147B
| $45.4M | 1.64% | 175,690 | – | – |
|
19
uniQure
QURE
$896M
| $44.9M | 1.62% | 2,393,311 +156,941 | +7% | +$2.94M |
|
20
Cardinal Health
CAH
$35.5B
| $42.7M | 1.54% | 639,783 | – | – |
|
21
AbbVie
ABBV
$372B
| $42.6M | 1.54% | 317,163 +70,928 | +29% | +$9.52M |
|
22
IQVIA
IQV
$32.4B
| $41.5M | 1.5% | 229,081 +7,385 | +3% | +$1.34M |
|
23
Avantor
AVTR
$9.18B
| $40.8M | 1.47% | 2,079,657 | – | – |
|
|
VERV
24
DELISTED
Verve Therapeutics
VERV
| $40.1M | 1.45% | 1,168,808 +323,622 | +38% | +$11.1M |
|
25
Dynavax Technologies
DVAX
$1.19B
| $39.7M | 1.44% | 3,805,370 | – | – |
|